FacebookTwitterRedditEmail

Dangerous, Expensive Drugs Aggressively Pushed? You Have These Medical Conflicts of Interest to Thank

Photo Source Damian Gadal | CC BY 2.0

The year was 2011. FDA Commissioner Margaret Hamburg proposed loosening conflict of interest rules for doctors sitting on advisory committees because non-compromised doctors were disappearing. The FDA could not find “knowledgeable experts who are free of financial conflicts of interest,” said news reports.

How bad is Pharma’s brazen financial infiltration into US medicine? The New York Times and ProPublica recently reported that Memorial Sloan Kettering Cancer Center’s own CEO, Dr. Craig B. Thompson, its chief medical officer, Dr. José Baselga, and one of its immunotherapy specialists, Dr. Jedd Wolchok, were swimming in Pharma money.

Thomas sat on the boards of Merck and Charles River Laboratories and actually founded a cancer start-up. Wolchok, says the Times and ProPublica, has links to 31 Pharma companies. Baselga, who has since resigned, received undisclosed millions from Pharma.

I have personally attended medical conferences where doctors unflinchingly show slide after slide of Pharma companies who pay them as if the payments did not affect their presentations to follow.

The responses of doctors exposed for the payola/bribes are downright embarrassing. Lee Cohen, lead author of a 2006 JAMA article promoting antidepressants during pregnancy listed 76 financial relationships with Pharma that he and the other authors had not mentioned explaining that, “We did not view those associations as relevant to this study.”

Entire hospital programs have been Pharma funded. Harvard child psychiatrist Joseph “Risperdal” Biederman approached Johnson & Johnson with a money-making scheme called the Johnson & Johnson Center for the Study of Pediatric Psychopathology at Massachusetts General Hospital to “move forward the commercial goals of J. & J.” and “support the safety and effectiveness of risperidone [Risperdal] in this age group.”

Dr. Mani Pavuluri, who received GlaxoSmithKline dollars, founded the Pediatric Mood Disorders Program and the Pediatric Brain Research and InterventioN (BRAIN) Center at the University of Illinois, conflicts of interest notwithstanding. She has since left in disgrace.

The corruption also affects our tax dollars. Despite leaving Emory University under a shameful cloud for not disclosing Pharma income and having a National Institutes of Health (NIH) grant terminated, Dr. Charles Nemeroff resurfaced at the University of Miami along with our tax dollars in what was widely regarded as undisguised cronyism.

Rather than stopping such conflicts of interest, mainstream medicine is moving toward legitimizing them. Dr. Timothy Wilens, chief of the division of child and adolescent psychiatry at Massachusetts General Hospital readily admits his “ties” to Pharma saying he has “an academic obligation to work with the industry.”

Duke’s Dr. Robert Califf, who became FDA Commissioner after Hamburg,said, “many of us consult with the pharmaceutical industry, which I think is a very good thing. They need ideas and then the decision about what they do is really up to the person who is funding the study.”

A disclosure statement on the website of Duke Clinical Research Institute says “Robert M. Califf, MD, reports receiving research grant support from Novartis Pharmaceuticals, Johnson & Johnson/Scios, Lilly, Merck, and Schering Plough, and consulting fees from Annenberg, Aterovax, Bayer/Ortho McNeil, BMS, Boehringer Ingelheim, GSK, WebMd/theheart.org, Johnson and Johnson/Scios, Kowa Research Institute, McKinsey & Company, Medtronic, Merck, Novartis Pharmaceuticals, Sanofi Aventis, and Schering Plough, and has an equity position with NITROX, LLC.”

Since Califf, Pharma operative Scott Gottlieb now heads the FDA and former Eli Lilly lobbyist Alex Azar now heads Health and Human Services in a clear message that government officials with Pharma ties are fine.

More articles by:

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

March 21, 2019
Daniel Warner
And Now Algeria
Renee Parsons
The Supreme Court and Dual Citizenship
Eric Draitser
On Ilhan Omar, Assad Fetishism, and the Danger of Red-Brown “Anti-Imperialism”
Elizabeth Keyes
Broadway’s “Hamilton” and the Willing Suspension of Reality-Based Moral Consciousness
David Underhill
Optional Fatherhood Liberates Christians From Abortion Jihad
Nick Pemberton
Is Kamala Harris the Centrist We Need?
Dean Baker
The Wall Street Bailouts, Bernie and the Washington Post
Russell Mokhiber
The Boeing Blackout
William Astore
America’s Senior Generals Find No Exits From Endless War
Jeff Hauser – Eleanor Eagan
Boeing Debacle Shows Need to Investigate Trump-era Corruption
Ramzy Baroud
Uniting Fatah, Not Palestinians: The Dubious Role of Mohammed Shtayyeh
Nick Licata
All Southern States are Not the Same: Mississippi’s Challenge
Jesse Jackson
Trump’s Sly Encouragement of Lawless Violence
Cesar Chelala
Public Health Challenges in Latin America and the Caribbean
March 20, 2019
T.J. Coles
Countdown to “Full Spectrum Dominance”
W. T. Whitney
Re-Targeting Cuba: Why Title III of U.S. Helms-Burton Act will be a Horror Show
Kenneth Surin
Ukania’s Great Privatization Heist
Howard Lisnoff
“Say It Ain’t So, Joe:” the Latest Neoliberal from the War and Wall Street Party
Walter Clemens
Jailed Birds of a Feather May Sing Together
George Ochenski
Failing Students on Climate Change
Cesar Chelala
The Sweet Smell of Madeleine
Binoy Kampmark
Global Kids Strike
Nicky Reid
Where Have All the Flowers Gone?: Requiem for a Fictional Party
Elliot Sperber
Empedocles and You and Me 
March 19, 2019
Paul Street
Socialism Curiously Trumps Fascism in U.S. Political Threat Reporting
Jonah Raskin
Guy Standing on Anxiety, Anger and Alienation: an Interview About “The Precariat”
Patrick Cockburn
The Brutal Legacy of Bloody Sunday is a Powerful Warning to Those Hoping to Save Brexit
Robert Fisk
Turning Algeria Into a Necrocracy
John Steppling
Day of Wrath
Robin Philpot
Truth, Freedom and Peace Will Prevail in Rwanda
Victor Grossman
Women Marchers and Absentees
Binoy Kampmark
The Dangers of Values: Brenton Tarrant, Fraser Anning and the Christchurch Shootings
Jeff Sher
Let Big Pharma Build the Wall
Jimmy Centeno
Venezuela Beneath the Skin of Imperialism
Jeffrey Sommers – Christopher Fons
Scott Walker’s Failure, Progressive Wisconsin’s Win: Milwaukee’s 2020 Democratic Party Convention
Steve Early
Time for Change at NewsGuild?
March 18, 2019
Scott Poynting
Terrorism Has No Religion
Ipek S. Burnett
Black Lives on Trial
John Feffer
The World’s Most Dangerous Divide
Paul Cochrane
On the Ground in Venezuela vs. the Media Spectacle
Dean Baker
The Fed and the 3.8 Percent Unemployment Rate
Thomas Knapp
Social Media Companies “Struggle” to Help Censors Keep us in the Dark
Binoy Kampmark
Death in New Zealand: The Christchurch Shootings
Mark Weisbrot
The Reality Behind Trump’s Venezuela Regime Change Coalition
Weekend Edition
March 15, 2019
Friday - Sunday
Andrew Levine
Is Ilhan Omar Wrong…About Anything?
FacebookTwitterRedditEmail